journal article·2021-05

Albumin-based nanoparticles combined with photodynamic therapy enhance the antitumor activity of curcumin derivative C086

Chen He, Lei Zhang, Wenzhen Liu, Yunmei Huang, Ping Hu, Tao Dai, Jianhua Xu, Zhuo Chen

Dyes and Pigments· Volume 189
Publisher page

Abstract

Abstract C086, a derivative of curcumin, was previously identified as a novel heat shock protein 90 (Hsp90) inhibitor and was found to exhibit stronger anti-tumor activity than curcumin. However, the inferior water solubility of C086 limits both its bioavailability and therapeutic efficacy. In this study, we aimed to improve the solubility and consequently the bioavailability of C086 via the albumin-based nanoparticles (NPs). The C086-loaded human serum albumin (C086@HSA) NPs were fabricated by a simple self-assembly method. The resulting C086@HSA NPs with an average diameter size of 36 nm, combined with photodynamic therapy, showed significant cytotoxic activity against all tumor cell lines investigated along with longer duration of effect than pure C086. More investigation was carried on the anti-tumor mechanism of C086@HSA NPs, showing that its anti-tumor effect of photodynamic therapy (PDT) on human cervical carcinoma HeLa cells was associated with apoptosis and cell cycle arrest at the S and G2/M phase upon 10-min blue light illumination (450 nm, 5 mW/cm2). Furthermore, the in vivo antitumor activity of C086@HSA NPs was evaluated in 4T1 tumor-bearing mouse model using intense blue light (80 mW/cm2), confirming the enhanced antitumor activity of C086@HSA NPs through photodynamic therapy. Taken together, our work provides an efficient albumin-based nanoparticle drug delivery platform to improve the bioavailability and therapeutic efficacy of hydrophobic photosensitizers against tumor growth.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Curcumin's Biomedical Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Targeted photodynamic therapy10.1002/lsm.20345 ↗
3. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy10.1002/lsm.21113 ↗
4. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
5. Strategies for enhanced photodynamic therapy effects10.1111/j.1751-1097.2007.00166.x ↗
6. Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells10.1111/j.1751-1097.2011.00992.x ↗
7. Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles10.1016/j.nano.2011.11.011 ↗
8. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy10.1016/j.apsb.2017.09.003 ↗
9. Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines10.1016/j.biomaterials.2015.11.009 ↗
10. Silica-based nanoparticles for biomedical applications: from nanocarriers to biomodulators10.1021/acs.accounts.0c00280 ↗
11. Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance
12. Development of curcumin-cyclodextrin/cellulose nanocrystals complexes: new anticancer drug delivery systems10.1016/j.bmcl.2015.12.060 ↗
13. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review10.1016/S0168-3659(99)00248-5 ↗
14. In vivo targeted delivery of nanoparticles for theranosis10.1021/ar2000138 ↗
15. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles10.1016/j.ijpharm.2007.03.036 ↗
16. Doxorubicin-bound albumin nanoparticles containing a TRAIL protein for targeted treatment of colon cancer10.1007/s11095-015-1814-z ↗
17. Novel difluoroboron complexes of curcumin analogues as “dual-dual” sensing materials for volatile acid and amine vapors10.1016/j.dyepig.2020.108406 ↗
18. Simultaneous dyeing and functionalization of silk with three natural yellow dyes10.1016/j.indcrop.2014.09.041 ↗
19. Curcumin nanoparticles: preparation, characterization, and antimicrobial study10.1021/jf104402t ↗
20. Curcumin delivery mediated by bio-based nanoparticles: a review10.3390/molecules25030689 ↗
21. Bioavailability of curcumin: problems and promises10.1021/mp700113r ↗
22. Application of different nanocarriers for encapsulation of curcumin10.1080/10408398.2018.1495174 ↗
23. Curcumin: from ancient medicine to current clinical trials10.1007/s00018-008-7452-4 ↗
24. Curcumin and endometriosis: review on potential roles and molecular mechanisms10.1016/j.biopha.2017.10.119 ↗
25. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials10.1002/ardp.200900319 ↗
26. Growth and proliferation of renal cell carcinoma cells is blocked by low curcumin concentrations combined with visible light irradiation10.3390/ijms20061464 ↗
27. Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model10.1002/ijc.23997 ↗
28. Evaluation of curcumin-mediated photodynamic therapy on the reverse of multidrug resistance in tumor cells10.1039/C9RA09996D ↗
29. Low dosed curcumin combined with visible light exposure inhibits renal cell carcinoma metastatic behavior in vitro10.3390/cancers12020302 ↗
30. Curcumin and its derivatives as potential therapeutic agents in prostate, colon and breast cancers10.3390/molecules24234386 ↗
31. Curcumin as a photosensitizer: from molecular structure to recent advances in antimicrobial photodynamic therapy10.1016/j.jphotochemrev.2020.100384 ↗
32. Diacetylcurcumin: a new photosensitizer for antimicrobial photodynamic therapy in Streptococcus mutans biofilms10.1080/08927014.2019.1606907 ↗
33. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFkappaB in colon cancer cells and xenograft tumors10.4161/cbt.12.9.17671 ↗
34. Synthesis and evaluation of 4-arylmethyl curcumin analgues as potent Hsp90 inhibitors10.2174/1570180811666140512221037 ↗
35. Novel Hsp90 inhibitor C086 potently inhibits non-small cell lung cancer cells as A single agent or in combination with gefitinib
36. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells10.1158/1078-0432.CCR-13-3317 ↗
37. Enhanced anti-hepatoma effect of a novel curcumin analog C086 via solid dispersion technology10.1080/10717544.2020.1785051 ↗
38. Curcumin-incorporated albumin nanoparticles and its tumor image10.1088/0957-4484/26/4/045603 ↗
39. Nanoparticle binding to urokinase receptor on cancer cell surface triggers nanoparticle disintegration and cargo release10.7150/thno.29445 ↗
40. Effects of hydroxyl radicals produced by a zinc phthalocyanine photosensitizer on tumor DNA10.1016/j.dyepig.2019.107894 ↗
41. Photodynamic oncotherapy mediated by gonadotropin-releasing hormone receptors10.1021/acs.jmedchem.7b01216 ↗